Human Papillomavirus
The Human Papillomavirus (HPV) vaccine protects against certain strains of HPV, a common virus that can lead to genital warts and various cancers, including cervical, anal, throat, and penile cancer. Vaccination is the most effective way to prevent HPV-related diseases.
HPV is a sexually transmitted virus, with most people being exposed at some point in their lives. While many infections resolve on their own, some strains can cause long-term health complications, including cancer. Vaccination significantly reduces the risk of infection and associated diseases.
Countries at Risk
HPV is a global health concern, with higher prevalence in regions with limited access to vaccination programs and cervical cancer screening:
Sub-Saharan Africa
South and Central America
Southeast Asia
Eastern Europe
Vaccination is recommended for individuals in all regions, regardless of travel plans, as HPV is widespread.
Travel Precautions
To reduce the risk of HPV-related diseases:
Get vaccinated before potential exposure.
Practice safe sexual health, including the use of condoms.
Regular screenings, such as Pap smears, for cervical health.
Signs & Symptoms
HPV often has no symptoms, but some strains can cause:
Genital warts: Small growths or bumps in the genital area.
Cancers: Including cervical, anal, throat, vulval, and penile cancer.
Vaccination is most effective when given before exposure to the virus, typically during adolescence.
The Vaccination
ourse: Single dose (for adults); younger individuals may require two or three doses based on age.
When to Vaccinate: Ideally between ages 11-12 but available for individuals up to 45 years.
Duration of Protection: Long-term immunity after a complete course.
Side Effects: Rare and mild, such as redness, swelling, or pain at the injection site, mild fever, or fatigue.
Who Should Vaccinate:Adolescents before becoming sexually active.
Adults up to age 45 seeking additional protection.
Pricing
Number of Doses: 1
Per Dose: £180.00
Full Course: £180.00